Unknown

Dataset Information

0

Inhibition of PARP1-dependent end-joining contributes to Olaparib-mediated radiosensitization in tumor cells.


ABSTRACT: Poly-ADP-ribose-polymerase inhibitors (PARPi) are considered to be optimal tools for specifically enhancing radiosensitivity. This effect has been shown to be replication-dependent and more profound in HR-deficient tumors. Here, we present a new mode of PARPi-mediated radiosensitization which was observed in four out of six HR-proficient tumor cell lines (responders) investigated, but not in normal cells. This effect is replication-independent, as the radiosensitization remained unaffected following the inhibition of replication using aphidicolin. We showed that responders are radiosensitized by Olaparib because their DSB-repair is switched to PARP1-dependent end-joining (PARP1-EJ), as evident by (i) the significant increase in the number of residual ?H2AX foci following irradiation with 3Gy and treatment with Olaparib, (ii) the enhanced enrichment of PARP1 at the chromatin after 3Gy and (iii) the inhibition of end-joining activity measured by a specific reporter substrate upon Olaparib treatment. This is the first study which directly demonstrates the switch to PARP1-EJ in tumor cells and its contribution to the response to Olaparib as a radiosensitizer, findings which could widen the scope of application of PARPi in tumor therapy.

SUBMITTER: Kotter A 

PROVIDER: S-EPMC5528607 | biostudies-literature | 2014 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Inhibition of PARP1-dependent end-joining contributes to Olaparib-mediated radiosensitization in tumor cells.

Kötter Annika A   Cornils Kerstin K   Borgmann Kerstin K   Dahm-Daphi Jochen J   Petersen Cordula C   Dikomey Ekkehard E   Mansour Wael Y WY  

Molecular oncology 20140701 8


Poly-ADP-ribose-polymerase inhibitors (PARPi) are considered to be optimal tools for specifically enhancing radiosensitivity. This effect has been shown to be replication-dependent and more profound in HR-deficient tumors. Here, we present a new mode of PARPi-mediated radiosensitization which was observed in four out of six HR-proficient tumor cell lines (responders) investigated, but not in normal cells. This effect is replication-independent, as the radiosensitization remained unaffected follo  ...[more]

Similar Datasets

| S-EPMC5295381 | biostudies-literature
| S-EPMC3040963 | biostudies-literature
| S-EPMC5125555 | biostudies-literature
| S-EPMC4769320 | biostudies-literature
| S-EPMC3819636 | biostudies-literature
| S-EPMC5765821 | biostudies-literature
| S-EPMC4184968 | biostudies-literature
| S-EPMC2952854 | biostudies-literature
| S-EPMC2943611 | biostudies-literature
| S-EPMC3604719 | biostudies-literature